Nanotechnology-Enhanced Chemoradiotherapy Using Copper and Gold Nanoparticles for Esophageal Cancer

Keyan Zang^1*

Nanotechnology might induce esophageal cancer treatment, enhancing patient outcomes with copper and gold nanoparticles boosting therapy efficacy and diagnostic precision.

Abstract

Background : Esophageal cancer is a severe malignancy originating from the cells of the esophagus, a long, hollow tube connecting the throat to the stomach. Current therapeutic and diagnostic approaches for esophageal cancer are insufficient, necessitating improved methods. Nanotechnology-enhanced chemoradiotherapy presents a promising avenue, with nanoparticle (NP) based delivery methods showing effectiveness in radiation, chemotherapy, and imaging. Methods: This study aimed to evaluate the efficacy of copper (Cu) and gold (Au) nanoparticles in enhancing patient outcomes, diagnostic accuracy, and therapeutic efficacy for esophageal cancer. The nanoparticles were prepared and characterized using Scanning Electron Microscopy (SEM). Their anti-esophageal cancer properties and in vitro cytotoxic effects were tested against three cancer cell lines: human Caucasian esophageal carcinoma (OE33), squamous cell carcinoma of the esophagus (KYSE-270), and esophageal junction adenocarcinoma (ESO26). The MTT assay was employed to assess cell viability, focusing on duration and concentration effects, while IC50 values were used to determine antioxidant activity. Results: Both Cu and Au nanoparticles demonstrated significant anti-esophageal cancer capabilities, reducing the viability of OE33, KYSE-270, and ESO26 cell lines in a dose- and time-dependent manner. Notably, Cu NPs exhibited higher antioxidant activity compared to Au NPs, as indicated by their IC50 values. This superior antioxidant activity is likely responsible for the enhanced efficacy of Cu NPs in preventing human esophageal cancer cell proliferation. Conclusion: The findings suggest that Cu and Au nanoparticles possess substantial anti-esophageal cancer properties, with Cu NPs showing higher antioxidant activity and greater potential in inhibiting cancer cell growth. The antioxidant qualities of these nanoparticles are crucial in their ability to prevent esophageal cancer, highlighting their promise as effective agents in nanotechnology-enhanced chemoradiotherapy for esophageal cancer treatment. Further research and clinical trials are warranted to explore their full therapeutic potential and application in clinical settings.

Keywords: Esophageal Cancer, Nanoparticles, Chemotherapy, Radiotherapy, Medical, Gold (Au) nanoparticles, Copper (Cu) nanoparticles

References

Khan, F., Shariq, M., Asif, M., Siddiqui, M. A., Malan, P., & Ahmad, F. (2022). Green nanotechnology: Plant-mediated nanoparticle synthesis and application. Nanomaterials, 12(4), 673.

Zhao, Z., Li, M., Zeng, J., Huo, L., Liu, K., Wei, R., Ni, K., & Gao, J. (2022). Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging. Bioactive Materials, 12, 214-245.

Gao, S., Zhang, W., Wang, R., Hopkins, S. P., Spagnoli, J. C., Racin, M., Bai, L., Li, L., Jiang, W., Yang, X., & Lee, C. (2020). Nanoparticles encapsulating nitrosylated maytansine to enhance radiation therapy. ACS Nano, 14(2), 1468-1481.

Atwan, Q. S., & Al-Ogaidi, I. (2024). Improving the targeted delivery of curcumin to esophageal cancer cells via a novel formulation of biodegradable lecithin/chitosan nanoparticles with downregulated miR-20a and miR-21 expression. Nanotechnology, 35(13), 135103.

Liang, M., Li, L. D., Li, L., & Li, S. (2022). Nanotechnology in diagnosis and therapy of gastrointestinal cancer. World Journal of Clinical Cases, 10(16), 5146.

Pedziwiatr-Werbicka, E., Horodecka, K., Shcharbin, D., & Bryszewska, M. (2021). Nanoparticles in combating cancer: Opportunities and limitations: A brief review. Current Medicinal Chemistry, 28(2), 346-359.

Buchman, J. T., Hudson-Smith, N. V., Landy, K. M., & Haynes, C. L. (2019). Understanding nanoparticle toxicity mechanisms to inform redesign strategies to reduce environmental impact. Accounts of Chemical Research, 52(6), 1632-1642.

Klekotka, U., Satula, D., Basa, A., & Kalska-Szostko, B. (2020). Importance of surfactant quantity and quality on growth regime of iron oxide nanoparticles. Materials, 13(7), 1747.

Zhang, X., Wang, M., Feng, J., Qin, B., Zhang, C., Zhu, C., Liu, W., Wang, Y., Liu, W., Huang, L., & Lu, S. (2022). Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer. Journal of Nanobiotechnology, 20(1), 166.

Gao, G., Zhou, W., Jiang, X., & Ma, J. (2024). Bovine serum albumin and folic acid-modified aurum nanoparticles loaded with paclitaxel and curcumin enhance radiotherapy sensitization for esophageal cancer. International Journal of Radiation Biology, 100(3), 411-419.

Didamson, O. C., & Abrahamse, H. (2021). Targeted photodynamic diagnosis and therapy for esophageal cancer: Potential role of functionalized nanomedicine. Pharmaceutics, 13(11), 1943.

Zhuang, X., Kang, Y., Zhao, L., & Guo, S. (2022). Design and synthesis of copper nanoparticles for the treatment of human esophageal cancer: Introducing a novel chemotherapeutic supplement. Journal of Experimental Nanoscience, 17(1), 274-284.

Xiao, Q., Zhang, Y., Zhao, A., Duan, Z., & Yao, J. (2023). Application and development of nanomaterials in the diagnosis and treatment of esophageal cancer. Frontiers in Bioengineering and Biotechnology, 11.

Deng, S., Gu, J., Jiang, Z., Cao, Y., Mao, F., Xue, Y., Wang, J., Dai, K., Qin, L., Liu, K., & Wu, K. (2022). Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer. Journal of Nanobiotechnology, 20(1), 415.

Moawad, M., Youssef, A. M., Elsherbeni, S. A. E., Fahmy, A. M., & El-Ghannam, G. (2024). Silver nanoparticles enhanced doxorubicin treatment for improving their efficacy against esophageal cancer cells. Egyptian Journal of Chemistry, 67(1), 505-512.

Poellmann, M. J., Bu, J., Liu, S., Wang, A. Z., Seyedin, S. N., Chandrasekharan, C., Hong, H., Kim, Y., Caster, J. M., & Hong, S. (2023). Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics, 226, 115117.

Liu, J., Zangeneh, A., Zangeneh, M. M., & Guo, B. (2020). Antioxidant, cytotoxicity, anti-human esophageal squamous cell carcinoma, anti-human Caucasian esophageal carcinoma, anti-adenocarcinoma of the gastroesophageal junction, and anti-distal esophageal adenocarcinoma properties of gold nanoparticles green synthesized by Rhus coriaria L. fruit aqueous extract. Journal of Experimental Nanoscience, 15(1), 202-216.

Alhussan, A., Bozdogan, E. P. D., & Chithrani, D. B. (2021). Combining gold nanoparticles with other radiosensitizing agents for unlocking the full potential of cancer radiotherapy. Pharmaceutics, 13(4), 442.

Ahmed, S., Rehman, S. U., & Tabish, M. (2022). Cancer nanomedicine: A step towards improving the drug delivery and enhanced efficacy of chemotherapeutic drugs. OpenNano, 7, 100051.

Liu, Z., Xie, Z., Li, W., Wu, X., Jiang, X., Li, G., Cao, L., Zhang, D., Wang, Q., Xue, P., & Zhang, H. (2021). Photodynamic immunotherapy of cancers based on nanotechnology: Recent advances and future challenges. Journal of Nanobiotechnology, 19(1), 160.

Jun, Y., Tang, Z., Luo, C., Jiang, B., Li, X., Tao, M., Gu, H., Liu, L., Zhang, Z., Sun, S. A., & Han, K. (2020). Leukocyte-mediated combined targeted chemo and gene therapy for esophageal cancer. ACS Applied Materials & Interfaces, 12(42), 47330-47341.